|
Name |
(5Z)-5-[(3,4-dihydroxy-5-methoxy-phenyl)methylene]-4-hydroxy-3-(4-hydroxyphenyl)furan-2-one
|
Molecular Formula | C18H14O7 | |
IUPAC Name* |
(5Z)-5-[(3,4-dihydroxy-5-methoxyphenyl)methylidene]-4-hydroxy-3-(4-hydroxyphenyl)furan-2-one
|
|
SMILES |
COC1=CC(=CC(=C1O)O)/C=C\2/C(=C(C(=O)O2)C3=CC=C(C=C3)O)O
|
|
InChI |
InChI=1S/C18H14O7/c1-24-13-7-9(6-12(20)16(13)21)8-14-17(22)15(18(23)25-14)10-2-4-11(19)5-3-10/h2-8,19-22H,1H3/b14-8-
|
|
InChIKey |
MYJVNAXQWDAVRD-ZSOIEALJSA-N
|
|
Synonyms |
CHEMBL4175853; (5Z)-5-[(3,4-dihydroxy-5-methoxy-phenyl)methylene]-4-hydroxy-3-(4-hydroxyphenyl)furan-2-one
|
|
CAS | NA | |
PubChem CID | 134815743 | |
ChEMBL ID | CHEMBL4175853 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 342.3 | ALogp: | 2.2 |
HBD: | 4 | HBA: | 7 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 116.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 25 | QED Weighted: | 0.498 |
Caco-2 Permeability: | -5.055 | MDCK Permeability: | 0.00001870 |
Pgp-inhibitor: | 0.012 | Pgp-substrate: | 0.017 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.989 |
30% Bioavailability (F30%): | 0.154 |
Blood-Brain-Barrier Penetration (BBB): | 0.03 | Plasma Protein Binding (PPB): | 95.14% |
Volume Distribution (VD): | 0.502 | Fu: | 5.93% |
CYP1A2-inhibitor: | 0.344 | CYP1A2-substrate: | 0.277 |
CYP2C19-inhibitor: | 0.117 | CYP2C19-substrate: | 0.063 |
CYP2C9-inhibitor: | 0.533 | CYP2C9-substrate: | 0.845 |
CYP2D6-inhibitor: | 0.061 | CYP2D6-substrate: | 0.238 |
CYP3A4-inhibitor: | 0.663 | CYP3A4-substrate: | 0.289 |
Clearance (CL): | 8.323 | Half-life (T1/2): | 0.833 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.191 |
Drug-inuced Liver Injury (DILI): | 0.694 | AMES Toxicity: | 0.056 |
Rat Oral Acute Toxicity: | 0.524 | Maximum Recommended Daily Dose: | 0.611 |
Skin Sensitization: | 0.614 | Carcinogencity: | 0.128 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.442 |
Respiratory Toxicity: | 0.227 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005411 | 0.808 | D0K8KX | 0.372 | ||||
ENC005410 | 0.766 | D04AIT | 0.366 | ||||
ENC003373 | 0.705 | D07MGA | 0.354 | ||||
ENC002800 | 0.598 | D06GCK | 0.353 | ||||
ENC001573 | 0.494 | D0AZ8C | 0.315 | ||||
ENC001548 | 0.477 | D0R6BI | 0.306 | ||||
ENC005039 | 0.469 | D06TJJ | 0.306 | ||||
ENC001771 | 0.455 | D04XEG | 0.287 | ||||
ENC002756 | 0.453 | D0E9CD | 0.286 | ||||
ENC002757 | 0.448 | D0Y7PG | 0.281 |